v3.26.1
Amended and Restated Condensed lnterim Consolidated Statements of Changes in Shareholders' Equity (Deficiency) (Unaudited) - CAD ($)
Issued capital [member]
Warrants [Member]
Contributed Surplus [Member]
Fair Value of the conversion option [Member]
Translation reserve
Deficit
Total
Balance as at January 1, 2025 at Dec. 31, 2024 $ 54,994,088 $ 761,495 $ 6,731,440 $ 41,846 $ (1,148,311) $ (72,797,613) $ (11,417,055)
Balance at beginning (in shares) at Dec. 31, 2024 195,647           195,647
IfrsStatementLineItems [Line Items]              
Issue of shares (Note 13) $ 244,500 (131,749) $ 112,751
Issue of shares, Shares 10,000            
Net loss for the period (1,689,530) (1,689,530)
Debenture conversion in share capital (Notes 12A) $ 831,749 831,749
Debenture conversion in share capital, Shares 11,666            
Foreign exchange in translation of foreign operations (107,740) (107,740)
Issue of warrants (Notes 13 and 14) (45,000) 45,000
Balance as at March 31, 2025 at Mar. 31, 2025 $ 56,025,337 806,495 6,731,440 (89,903) (1,256,051) (74,487,143) (12,269,825)
Balance at ending (in shares) at Mar. 31, 2025 217,313            
Balance as at January 1, 2025 at Dec. 31, 2025 $ 86,606,375 6,465,936 7,559,538 (801,802) (94,233,661) $ 5,596,387
Balance at beginning (in shares) at Dec. 31, 2025 13,069,567           13,069,567
IfrsStatementLineItems [Line Items]              
Issue of shares (Note 13) $ 47,796 $ 47,796
Issue of shares, Shares 15,149            
Net loss for the period (2,166,574) (2,166,574)
Foreign exchange in translation of foreign operations (291,997) (291,997)
Issue of warrants (Notes 13 and 14) 4,803 4,803
Balance as at March 31, 2025 at Mar. 31, 2026 $ 86,654,171 $ 6,470,739 $ 7,559,538 $ (1,093,799) $ (96,400,235) $ 3,190,415
Balance at ending (in shares) at Mar. 31, 2026 13,084,716           13,084,716